Proton pump inhibitors: very low risk of subacute cutaneous lupus erythematosus
Proton pump inhibitors (PPIs) are associated with very infrequent cases of subacute cutaneous lupus erythematosus (SCLE), a non-scarring dermatosis that can develop in sun-exposed areas.
Download the Yellow Card mobile app to report suspected adverse drug reactions
On 14 July 2015, the Yellow Card mobile app was launched – use it to report suspected reactions and receive up to date information on your medicines of interest.
Pseudoephedrine and ephedrine: update on managing risk of misuse in the UK
Implementation of measures to regulate sales, together with the additional voluntary actions overseen by the pharmacy profession, has made an important contribution to managing the risk of misuse of pseudoephedrine and ephedrine in the UK.
Letters sent to healthcare professionals in August 2015
A letter was sent regarding InductOs (solvent and matrix for implantation) to inform of a potential shortage.